Evolus, Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Evolus, Inc. is a performance beauty company that develops and markets aesthetic products, including Jeuveau, an injectable neurotoxin used to temporarily reduce moderate-to-severe frown lines, as well as dermal fillers and body-contouring treatments.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| MOATAZEDI DAVIDSee Remarks | Sell | $950K | 105,108at $9.04 | Sep 2, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable EOLS activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.